Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Investigation

• Publication date

  2009-11-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI36308PMID 19809158PMCID PMC2769187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.

  2009cited by this paper
• Semaphorin signaling: progress made and promises ahead.

  2008influential reference
• The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment

  2008cited by this paper
• Vascular normalization in Rgs5-deficient tumours promotes immune destruction

  2008cited by this paper
• The semaphorins: versatile regulators of tumour progression and tumour angiogenesis

  2008cited by this paper
• Cancer gene therapy using adeno-associated virus vectors.

  2008cited by this paper
• Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor.

  2008cited by this paper
• Successful Inhibition of Tumor Development by Specific Class-3 Semaphorins Is Associated with Expression of Appropriate Semaphorin Receptors by Tumor Cells

  2008influential reference
• FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

  2008cited by this paper
• Perivascular nitric oxide gradients normalize tumor vasculature

  2008cited by this paper
• Semaphorin-3A and Semaphorin-3F Work Together to Repel Endothelial Cells and to Inhibit Their Survival by Induction of Apoptosis*

  2007cited by this paper
• Targeting endothelial and tumor cells with semaphorins

  2007cited by this paper
• Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.

  2007cited by this paper
• Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.

  2007cited by this paper
• Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.

  2007influential reference
• Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A.

  2006cited by this paper
• Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes.

  2006cited by this paper
• Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma.

  2006cited by this paper
• Vascular endothelial-derived semaphorin 3 inhibits sympathetic axon growth.

  2006cited by this paper
• Neuropilins in neoplasms: expression, regulation, and function.

  2006cited by this paper
• Nitric oxide signaling: no longer simply on or off.

  2006cited by this paper
• Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.

  2006cited by this paper
• A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord

  2006cited by this paper
• Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma.

  2006cited by this paper
• Semaphoring vascular morphogenesis.

  2006cited by this paper
• Lessons from phase III clinical trials on anti-VEGF therapy for cancer

  2006influential reference
• Integrins and angiogenesis: a sticky business.

  2006cited by this paper
• The neuropilins and their role in tumorigenesis and tumor progression.

  2006cited by this paper
• Gene promoter methylation in prostate tumor-associated stromal cells.

  2006cited by this paper
• Common mechanisms of nerve and blood vessel wiring

  2005cited by this paper
• Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

  2005influential reference
• Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

  2005influential reference
• Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors.

  2005cited by this paper
• PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

  2005cited by this paper
• Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis.

  2005cited by this paper
• Endothelial/Pericyte Interactions

  2005cited by this paper
• Plexin D1 expression is induced on tumor vasculature and tumor cells: a novel target for diagnosis and therapy?

  2005cited by this paper
• Uniform Overexpression and Rapid Accessibility of α5β1 Integrin on Blood Vessels in Tumors

  2005cited by this paper
• An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

  2004influential reference
• Differential MAP kinases activation during semaphorin3A-induced repulsion or apoptosis of neural progenitor cells.

  2004cited by this paper
• Semaphorin-3F Is an Inhibitor of Tumor Angiogenesis

  2004cited by this paper
• Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.

  2004cited by this paper
• Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

  2004cited by this paper
• Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2.

  2004cited by this paper
• Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

  2004cited by this paper
• Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.

  2003cited by this paper
• Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function

  2003influential reference
• Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis.

  2003cited by this paper
• In Vitro and in Vivo Characterization of a Novel Semaphorin 3A Inhibitor, SM-216289 or Xanthofulvin*

  2003cited by this paper
• Inhibition of integrin α5β1 function with a small peptide (ATN‐161) plus continuous 5‐FU infusion reduces colorectal liver metastases and improves survival in mice

  2003cited by this paper
• Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

  2003influential reference
• Inhibition of endothelial cell survival and angiogenesis by protein kinase A.

  2002cited by this paper
• VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.

  2002cited by this paper
• Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

  2002cited by this paper
• A reevaluation of integrins as regulators of angiogenesis

  2002cited by this paper
• Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins.

  2001cited by this paper
• Anoikis.

  2000cited by this paper
• The basic helix-loop-helix transcription factor, dHAND, is required for vascular development.

  2000influential reference
• Repulsive axon guidance molecule Sema3A inhibits branching morphogenesis of fetal mouse lung.

  2000cited by this paper
• Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

  2000cited by this paper
• Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.

  1999influential reference
• Semaphorins as Mediators of Neuronal Apoptosis

  1999cited by this paper
• Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice.

  1997cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice.

  1996cited by this paper
• Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.

  1996influential reference
• Monoclonal Antibody 9EG7 Defines a Novel β1 Integrin Epitope Induced by Soluble Ligand and Manganese, but Inhibited by Calcium (*)

  1995cited by this paper
• A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta 1.

  1993cited by this paper
• Induction of angiogenesis during the transition from hyperplasia to neoplasia

  1989cited by this paper
• Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.

  1985cited by this paper
• Integrin (cid:1) 1 Subunit Controls Mural Cell Adhesion, Spreading, and Blood Vessel Wall Stability

  year unknowncited by this paper

• Papain induces Mitochondria-mediated apoptosis and modulates inflammatory signaling in leukemic cells

  2026cites this paper
• Electrochemical mass spectrometry coupled transcriptomics to investigate nitric oxide metabolism and its modulation by Saikosaponin D in breast cancer cells

  2026cites this paper
• A stumbling block in pancreatic cancer treatment: drug resistance signaling networks

  2025cites this paper
• Autocrine Semaphorin 6B Signaling Is Essential for Tumorigenesis in Lung Cancer

  2025cites this paper
• Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer

  2025cites this paper
• Semaphorin 3A and 3F overexpression in TIE2 hyperactive endothelial cells contribute to the pathological lumen expansion in venous malformation

  2025cites this paper
• Reduced expression of semaphorin 3A in osteoclasts causes lymphatic expansion in a Gorham-Stout disease (GSD) mouse model

  2024cites this paper
• Semaphorins in tumor microenvironment: Biological mechanisms and therapeutic progress.

  2024cites this paper
• The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes

  2024cites this paper
• Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism

  2024cites this paper
• Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma

  2024cites this paper
• Role of Semaphorins, neuropilins and plexins in cancer progression.

  2024cites this paper
• Plexins as Regulators of Cancer Cell Proliferation, Migration, and Invasivity

  2023cites this paper
• Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer.

  2023cites this paper
• mRNA-lncRNA gene expression signature for predicting pediatric AML relapse.

  2023cites this paper
• Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival

  2023cites this paper
• Sodium Valproate Enhances Semaphorin 3A-mediated Anti-angiogenesis and Tumor Growth Inhibition in Human Osteosarcoma Cells

  2023cites this paper
• Advances in SEMA3F regulation of clinically high-incidence cancers

  2023cites this paper
• Emerging roles and mechanisms of semaphorins activity in cancer.

  2023cites this paper
• The role of semaphorins in allergic diseases.

  2023cites this paper
• Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination.

  2023cites this paper
• Alleviating hypoxia to improve cancer immunotherapy

  2023cites this paper
• Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

  2022cites this paper
• Semaphorin3F reduces vascular endothelial and smooth muscle cell PI3K activation and decreases neointimal plaque formation

  2022cites this paper
• Stroma-targeting strategies in pancreatic cancer: a double-edged sword

  2022cites this paper
• Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications

  2022cites this paper
• Management of Advanced Pancreatic Cancer through Stromal Depletion and Immune Modulation

  2022cites this paper
• The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies

  2022cites this paper
• Endothelial VEGFR Coreceptors Neuropilin-1 and Neuropilin-2 Are Essential for Tumor Angiogenesis

  2022cites this paper
• The Sympathetic Nervous System Contributes to the Establishment of Pre-Metastatic Pulmonary Microenvironments

  2022cites this paper
• Induction of PLXNA4 Gene during Neural Differentiation in Human Umbilical-Cord-Derived Mesenchymal Stem Cells by Low-Intensity Sub-Sonic Vibration

  2022cites this paper
• The significance of HERC5, IFIH1, SAMD4, SEMA3A and MCTP1 genes expression in resistance to cytotoxic drugs in ovarian cancer cell lines

  2021cites this paper
• Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment

  2021cites this paper
• Semaphorin 3A Levels in Lupus With and Without Secondary Antiphospholipid Antibody Syndrome and Renal Involvement.

  2021cites this paper
• Neuropilin 1 Regulation of Vascular Permeability Signaling

  2021cites this paper
• The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options

  2021cites this paper
• Cerebrovascular development: mechanisms and experimental approaches

  2021cites this paper
• SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia

  2021cites this paper
• Sema3A accelerates bone formation during distraction osteogenesis in mice

  2021cites this paper
• Class-3 semaphorins: Potent multifunctional modulators for angiogenesis-associated diseases.

  2021cites this paper
• Biomarkers for detecting and improving AKI after liver transplantation: From diagnosis to treatment.

  2021cites this paper
• Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model

  2021cites this paper
• Neuropilin: Handyman and Power Broker in the Tumor Microenvironment.

  2020cites this paper
• Sema3A and HIF1α co‐overexpressed iPSC‐MSCs/HA scaffold facilitates the repair of calvarial defect in a mouse model

  2020cites this paper
• Compromised angiogenesis and vascular Integrity in impaired diabetic wound healing

  2020influential citation
• HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction

  2020cites this paper
• CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth

  2020cites this paper
• The role of semaphorins in small vessels of the eye and brain.

  2020cites this paper
• Characterization of Class-3 Semaphorin Receptors, Neuropilins and Plexins, as Therapeutic Targets in a Pan-Cancer Study

  2020cites this paper
• The Role of Semaphorins in Metabolic Disorders

  2020cites this paper
• Pancreatic cancer stroma: an update on therapeutic targeting strategies

  2020cites this paper
• Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma

  2020cites this paper
• Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?

  2020cites this paper
• The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal Cancer

  2019cites this paper
• Reprogramming of Rat Hepatoma Cells with Fibroblast-specific Protein Twist1

  2019cites this paper
• Multifaceted Functional Role of Semaphorins in Glioblastoma

  2019cites this paper
• Premetastasis.

  2019cites this paper
• Potential involvement of semaphorin 3A in maintaining intervertebral disc tissue homeostasis

  2019cites this paper
• Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges.

  2019cites this paper
• Alternative Strategies to Inhibit Tumor Vascularization

  2019cites this paper
• Skilled Movements in Mice Require Inhibition of Corticospinal Axon Collateral Formation in the Spinal Cord by Semaphorin Signaling

  2019influential citation
• Transformation of the Transcriptomic Profile of Mouse Periocular Mesenchyme During Formation of the Embryonic Cornea

  2019cites this paper
• Neuropilins in the Context of Tumor Vasculature

  2019cites this paper
• Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis.

  2019cites this paper
• Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression

  2019cites this paper
• The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications

  2019cites this paper
• Targeting Semaphorin 3C in Prostate Cancer With Small Molecules

  2018cites this paper
• Guidance Molecules in Vascular Smooth Muscle

  2018cites this paper
• Making Connections: Guidance Cues and Receptors at Nonneural Cell-Cell Junctions.

  2018cites this paper
• miR-126-5p promotes retinal endothelial cell survival through SetD5 regulation in neurons

  2018influential citation
• Neuroimmune Semaphorin 4A in Cancer Angiogenesis and Inflammation: A Promoter or a Suppressor?

  2018influential citation
• Semaphorin-3A inhibits multiple myeloma progression in a mouse model

  2018cites this paper
• Angiogenesis in pancreatic cancer: current research status and clinical implications

  2018cites this paper
• Mouse models of peripheral metabolic disease.

  2018cites this paper
• Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models.

  2018cites this paper
• Semaphorin 3A enhances osteogenesis of MG63 cells through interaction with Schwann cells in vitro.

  2018cites this paper
• Nova2 alternative splicing regulation of the netrin receptor Unc5b during angiogenesis

  2018cites this paper
• A mechanism for semaphorin-induced apoptosis: DNA damage of endothelial and myogenic cells in primary cultures from skeletal muscle

  2018cites this paper
• A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent

  2018cites this paper
• The role of semaphorins in immune responses and autoimmune rheumatic diseases

  2018cites this paper
• Impaired Angiogenic Supportive Capacity and Altered Gene Expression Profile of Resident CD146+ Mesenchymal Stromal Cells Isolated from Hyperoxia-Injured Neonatal Rat Lungs

  2018cites this paper
• New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines

  2018cites this paper
• Chromatin association of XRCC5/6 in the absence of DNA damage depends on the XPE gene product DDB2

  2017cites this paper
• The Role of the Neuropilins in Developmental Angiogenesis

  2017cites this paper
• Nanotechnology for delivery of gemcitabine to treat pancreatic cancer.

  2017cites this paper
• Sprouting strategies and dead ends in anti-angiogenic targeting of NETs.

  2017cites this paper
• Shear stress-regulated miR-27b controls pericyte recruitment by repressing SEMA6A and SEMA6D

  2017cites this paper
• Tumor angiogenesis revisited: Regulators and clinical implications

  2017cites this paper
• Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy

  2017cites this paper
• The Neuropilins and Their Ligands in Hematogenous Metastasis of Salivary Adenoid Cystic Carcinoma-An Immunohistochemical Study.

  2017influential citation
• Characterization of Semaphorin 6A-Mediated Effects on Angiogenesis Through Regulation of VEGF Signaling.

  2017cites this paper
• Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program

  2017cites this paper
• Semaphorins and their Signaling Mechanisms.

  2017cites this paper
• Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice

  2017cites this paper
• Neuropilin-1-Expressing Monocytes: Implications for Therapeutic Angiogenesis and Cancer Therapy

  2017cites this paper
• Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors

  2017cites this paper
• Semaphorin Signaling

  2017cites this paper
• Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling

  2016cites this paper
• Human airway smooth muscle cell proliferation from asthmatics is negatively regulated by semaphorin3A

  2016cites this paper
• The role of the semaphorins in cancer

  2016cites this paper